A global leader in the healthcare and life sciences sectors, the company specializes in developing innovative pharmaceuticals, biotech products, and high-performance materials. Investors closely monitor its performance due to its strong R&D pipeline and strategic positioning in key growth markets.
2 members of Congress have disclosed 2 trades in Merck KGaA (MKKGY), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-10 | Daniel Goldman | sell | $1K – $15K |
| 2015-11-18 | Angus S King, Jr. | sell | $15K – $50K |